Inflammation  >>  peginterferon alfa 2b 48kDA (BIP48)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
peginterferon alfa 2b 48kDA (BIP48) / Oswaldo Cruz Foundation
NCT01623336: BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C

Unknown status
2/3
740
RoW
BIP 48 (Peginterferon alfa 2b 48kDA), Peginterferon alfa 2a 40kDA, Pegasys ®
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz), Hospital de Clinicas de Porto Alegre
Chronic Hepatitis C
08/16
12/16

Download Options